Category Archives: Health Care

Health Care

Revolutionary Fetal Surgery in UAE for Spina Bifida

Landmark procedure strengthens the UAE’s position in advanced fetal care and complex prenatal interventions.

Abu Dhabi, April 27, 2026: Danat Al Emarat Women and Children’s Hospital, part of the M42 group, has successfully performed a minimally invasive fetoscopic keyhole repair for spina bifida, the first-ever procedure of this kind at the hospital. Unlike traditional open fetal surgery used in similar cases, this advanced in utero procedure was completed using a minimally invasive approach.

This achievement marks a significant advancement in maternal and fetal care in the UAE, expanding in-country capability to manage complex prenatal conditions and reducing the need for families to seek treatment abroad.  

Continue reading Revolutionary Fetal Surgery in UAE for Spina Bifida →
Health Care

Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework

  • Strategic framework established for regional and global licensing, frontier technology incubation, and strategic collaboration in neurodegenerative diseases
  • Joint R&D aligned with China-UAE bilateral partnership and Abu Dhabi’s Healthcare Life Sciences Vision 2030

Abu Dhabi, United Arab Emirates and Shanghai, China, April 28, 2026 – Arcera Life Sciences (“Arcera”), a global life sciences company headquartered in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co., Ltd. (“Fosun Pharma”), an innovation-driven global pharmaceutical and healthcare group, today announced the signing of a Memorandum of Understanding (MoU) to establish a long-term strategic collaboration focused on licensing, technology development, neuroscience innovation and value creation in the global life sciences sector.

The agreement was executed by Sunil Bhilotra, Chief Investment Officer of Arcera, and Xingli Wang, Co-President of Fosun Pharma, CEO of Innovative Medicines Division in Shanghai, China. The signing ceremony was witnessed by Qunbin Wang, Co-Chairman of Fosun International; Yuqing Chen, Chairman of Fosun Pharma; Isabel Afonso, Chief Executive Officer of Arcera; and Rafael Ferrer, SVP Corporate Development of Arcera.

Continue reading Arcera Life Sciences and Fosun Pharma launch long-term collaboration framework →
Health Care

PureHealth Achieves AAHRPP Accreditation for Clinical Research

Abu Dhabi, 28 April 2026: PureHealth, the largest healthcare group in the Middle East, has achieved full accreditation from the Association for the Accreditation of Human Research Protection Programs (AAHRPP) for its SEHA and Sheikh Shakhbout Medical City (SSMC) entities, recognising the strength of the group’s clinical research capabilities.

The research divisions of both entities operate under the Abu Dhabi Health Research Centre (ADHRC), PureHealth’s integrated clinical research hub, which consolidates activity across 16 hospitals, primary care clinics and advanced laboratories in Abu Dhabi. With more than 200 active studies spanning early and advanced clinical trials, as well as translational research, ADHRC is underpinned by a unified governance framework that strengthens oversight and enables high-quality research at scale.

Continue reading PureHealth Achieves AAHRPP Accreditation for Clinical Research →
Health Care

Dubai’s Medcare Hospital becomes world’s first to treat adult Spinal Muscular Atrophy (SMA) patient outside the US

  • The 22-year-old Egyptian patient travelled to Dubai to receive the transformative one-time treatment at Medcare Royal Specialty Hospital for his genetic neuromuscular condition. This marks a significant advancement in gene therapy, as this patient is the second adult SMA patient worldwide to be treated with Novartis’ Itvisma as independently verified by the manufacturer Novartis
  • Medcare was the first private healthcare provider worldwide to administer the newly licensed Itvisma to a four-year-old international SMA patient last year, also confirmed by the manufacturer Novartis.
  • The prevalence of SMA is estimated to be approximately 1 to 2 in 100,000 persons and DMD is estimated to be 1 in 3500 boys worldwide. Since 2020, Medcare has treated over 190 SMA patients and 20 DMD patients with revolutionary gene therapies.

Dubai, UAE – April 28, 2026: Medcare Royal Speciality Hospital (MRSH) in Dubai has become the world’s first hospital outside the USA to offer a newly licensed intrathecal gene therapy to any adult patients with Spinal Muscular Atrophy (SMA). This one-time, life-altering treatment was recently administered to a 22-year-old Egyptian patient who had spent most of his life confined to a wheelchair, with few treatment options available. His case marks a decisive shift in the treatment landscape for SMA, a rare genetic disorder that progressively prevents patients from movement, independence, and, in severe cases, the ability to breathe.

Continue reading Dubai’s Medcare Hospital becomes world’s first to treat adult Spinal Muscular Atrophy (SMA) patient outside the US →
Health Care

M42’s Strategy Enhances Access to Kidney Treatment in Brazil

  • Expansion strengthens Diaverum’s footprint in Brazil with 18 clinics and 3 vascular access centers
  • Growing footprint tackles chronic kidney disease, a public health issue, with over 220,000 treatments annually
  • Acquisition underpins M42’s strategy to build globally connected care platforms to improve access to high-quality care in line with data sovereignty regulations

Abu Dhabi, UAE – 23 April 2026: M42, a global health leader powered by AI, technology and genomics, and its world leading renal care business, Diaverum, today announced the completion of a strategic acquisition of four clinics in the state of São Paulo, Brazil, from the Lund Group: CDTR and CDTR Prime in Sorocaba, INDI in Itapetininga, and Lund Nefrologia in Itu. The move takes Diaverum clinics to 18 in Brazil, including three vascular access centers, affirming its long-term commitment to improving access to renal care and supporting better health outcomes in Latin America’s largest market.

Continue reading M42’s Strategy Enhances Access to Kidney Treatment in Brazil →